Nwamaka C. Bob-Ume

Innovations in Drug-Coated Balloons and Stentless Coronary Interventions: Evaluating the Evidence, Limitations, and Future Prospects in De-Novo Lesion Management

George Davidson, Nwachukwu O. Nwachukwu, Chimaobi Nwevo, Ahmed Ismail Ali, Nwamaka C. Bob-Ume, Abduljabbar A. Abdulaziz, Adu Agyen Kwame, Muhiyadin S. Ali, Alexander C. Ogbodo & Obinna D. Nwaizuzu · Cardiology and Angiology: An International Journal · 2026

Coronary artery disease (CAD) remains a major cause of morbidity and mortality, and percutaneous coronary intervention (PCI) is central to the management of obstructive coronary disease. Although drug-eluting stents (DESs) have reduced restenosis and repeat revascularisation, the...

Open access Research Article 10.9734/ca/2026/v15i3553

TAVR vs. SAVR in Low-risk Aortic Stenosis: A Systematic Review and Meta-analysis of Safety and Efficacy

Destiny C. Chinuokwu, Jingwa A. Klein, Daniel E. Otobrise, Peace Mordi, Nwamaka C. Bob-Ume, Belinda A. Eze, Ranjan Aishwarya, Abdelatty M.S. Abdelrahman, Vansh R. Roshni, Ezeamaku-Humphrey P. Chisom, Nasre S. Vaibhav, Yadav P. Cyrus, Msalm E.M. Manar, Cueva R.A. Nikol & Samuel F. Chidera · Asian Journal of Research in Cardiovascular Diseases · 2025

Background: Transcatheter aortic valve replacement (TAVR) is a transformative intervention for severe aortic stenosis (AS), particularly in high- and intermediate-risk patients. However, its role in low-risk individuals remains under investigation. Aim: This systematic review and...

Open access Research Article 10.9734/ajrcd/2025/v7i1136